Although patients underwent a standardised detailed investigation pathway, investigations such as transoesophageal echocardiogram, urine toxicology screening and extended thrombophilia screening (including protein C and S, and antithrombin III) were only performed in select cases. The gene discussed is SERPINC1; the disease is Rare hereditary thrombophilia.